EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting the CCL2/CCR2 Axis in HIV-1 Infection and Ischemic Stroke

Silvia Torices iD, Daniela Iglesias Gallo iD, Enrique Lara iD, Sierra Simecek, Sierra Simon iD, Nykkie Okoro, Sandy Del Sol, Michal Toborek iD

Stroke · 2026

DOI: 10.1161/strokeaha.125.051965 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stroke, 2026. Verfasst von Silvia Torices und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, FL. Hauptthemen laut MEDLINE: Receptors, CCR2, HIV Infections, Chemokine CCL2, Ischemic Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIEHS NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV-associated comorbidities, including cardiovascular and cerebrovascular events, are frequent diseases in people living with HIV. Notably, the prevalence of ischemic stroke is 3× higher in people living with HIV than in noninfected individuals, making it one of the most significant cerebrovascular events in people living with HIV. Despite this close association, the mechanisms involved in the enhanced incidence of ischemic stroke in HIV infection remain poorly understood. A chemokine CCL2 (C-C motif chemokine ligand 2), acting via its receptor CCR2 (C-C chemokine receptor type 2), is a prominent chemoattractant involved in the recruitment of CD4+T cells and monocytes/macrophages, which are primary targets for HIV infection. Due to its role in directing leukocyte migration into the brain and enhancing blood-brain barrier permeability, CCL2 is also a critical mediator of neuroinflammation after brain damage, such as ischemic stroke. In this review, we examine the role of the CCL2/CCR2 signaling pathway in HIV infection, its influence on the progression of ischemic stroke outcome and recovery, and propose the CCL2/CCR2 axis as a possible therapeutic target in people living with HIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CCR2HIV InfectionsChemokine CCL2Ischemic StrokeHIV-1HumansSignal TransductionAnimalsBlood-Brain Barrier

Stichwörter der Autor:innen

CCL2HIV-1braininflammationischemic stroke

Substanzen

Receptors, CCR2Chemokine CCL2CCR2 protein, humanCCL2 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, FL.

ORCID-Profile: Silvia Torices, Daniela Iglesias Gallo, Enrique Lara, Sierra Simon, Michal Toborek

Förderung

  • NIDA NIH HHS
  • NIEHS NIH HHS
  • NIMH NIH HHS
  • NINDS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Torices, S., Iglesias Gallo, D., Lara, E., Simecek, S., Simon, S., Okoro, N., Del Sol, S., & Toborek, M. (2026). Targeting the CCL2/CCR2 Axis in HIV-1 Infection and Ischemic Stroke. Stroke. https://doi.org/10.1161/strokeaha.125.051965

Vancouver

Torices S, Iglesias Gallo D, Lara E, Simecek S, Simon S, Okoro N, et al. Targeting the CCL2/CCR2 Axis in HIV-1 Infection and Ischemic Stroke. Stroke. 2026. doi:10.1161/strokeaha.125.051965

BibTeX
@article{Torices2026,
  author = {Torices, Silvia and Iglesias Gallo, Daniela and Lara, Enrique and Simecek, Sierra and Simon, Sierra and Okoro, Nykkie and Del Sol, Sandy and Toborek, Michal},
  title = {Targeting the CCL2/CCR2 Axis in HIV-1 Infection and Ischemic Stroke},
  journal = {Stroke},
  year = {2026},
  doi = {10.1161/strokeaha.125.051965}
}
Kostenlos starten →